India Capital Growth (IGC) Competitors GBX 175 0.00 (0.00%) As of 03:44 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock IGC vs. SLN, AMYT, OGN, BMY, GPH, AURA, ARTL, PHAR, KOD, and ORPHShould you be buying India Capital Growth stock or one of its competitors? The main competitors of India Capital Growth include Silence Therapeutics (SLN), Amryt Pharma (AMYT), Origin Enterprises (OGN), Bloomsbury Publishing (BMY), Global Ports (GPH), Aura Energy (AURA), Alpha Real Trust (ARTL), Pharos Energy (PHAR), Kodal Minerals (KOD), and Open Orphan (ORPH). These companies are all part of the "pharmaceutical products" industry. India Capital Growth vs. Its Competitors Silence Therapeutics Amryt Pharma Origin Enterprises Bloomsbury Publishing Global Ports Aura Energy Alpha Real Trust Pharos Energy Kodal Minerals Open Orphan Silence Therapeutics (LON:SLN) and India Capital Growth (LON:IGC) are both small-cap pharmaceutical products companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends, earnings and media sentiment. Which has higher valuation & earnings, SLN or IGC? India Capital Growth has higher revenue and earnings than Silence Therapeutics. Silence Therapeutics is trading at a lower price-to-earnings ratio than India Capital Growth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSilence Therapeutics£11.35M0.00N/A-£48.60N/AIndia Capital Growth£46.21M3.27£43.14M£49.523.53 Does the media refer more to SLN or IGC? In the previous week, India Capital Growth had 3 more articles in the media than Silence Therapeutics. MarketBeat recorded 3 mentions for India Capital Growth and 0 mentions for Silence Therapeutics. India Capital Growth's average media sentiment score of 1.00 beat Silence Therapeutics' score of 0.00 indicating that India Capital Growth is being referred to more favorably in the news media. Company Overall Sentiment Silence Therapeutics Neutral India Capital Growth Positive Is SLN or IGC more profitable? India Capital Growth has a net margin of 93.35% compared to Silence Therapeutics' net margin of 0.00%. India Capital Growth's return on equity of 25.12% beat Silence Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Silence TherapeuticsN/A N/A N/A India Capital Growth 93.35%25.12%15.98% Do insiders and institutionals hold more shares of SLN or IGC? 24.3% of India Capital Growth shares are owned by institutional investors. 0.2% of India Capital Growth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryIndia Capital Growth beats Silence Therapeutics on 10 of the 10 factors compared between the two stocks. Get India Capital Growth News Delivered to You Automatically Sign up to receive the latest news and ratings for IGC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IGC vs. The Competition Export to ExcelMetricIndia Capital GrowthAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£151.09M£1.30B£6.50B£3.19BDividend YieldN/A4.41%4.17%5.04%P/E Ratio3.5322.5914.29166.38Price / Sales3.272,431.731,761.25470,294.01Price / Cash97.3160.62127.5127.93Price / Book0.881.395.296.41Net Income£43.14M£265.04M£1.23B£5.89B7 Day Performance-2.74%0.28%0.76%0.82%1 Month Performance-3.31%0.83%2.20%49.22%1 Year Performance-6.42%6.48%24.86%133.18% India Capital Growth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IGCIndia Capital GrowthN/AGBX 175flatN/A-6.4%£151.09M£46.21M3.5361SLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumeAMYTAmryt PharmaN/AN/AN/AN/A£457.11M£210.24M-4.33290Gap DownOGNOrigin EnterprisesN/AGBX 3.75-0.1%N/AN/A£395.43M£183.08B10.8310,000Dividend IncreaseBMYBloomsbury Publishing3.1986 of 5 starsGBX 487.50-1.3%GBX 825+69.2%-33.1%£393.38M£382.40M10.4334,300GPHGlobal PortsN/AN/AN/AN/A£231.21M£193.58M30,000.0020AURAAura EnergyN/AGBX 7.23-3.7%N/A+15.1%£129.86MN/A-15,837.3550Gap DownARTLAlpha Real TrustN/AN/AN/AN/A£113.12M£8.46M96.445Gap UpHigh Trading VolumePHARPharos EnergyN/AGBX 20.80-1.9%N/A-15.1%£103.76M£196.07M-2.21280Positive NewsKODKodal Minerals1.6325 of 5 starsGBX 0.34-3.9%GBX 1.23+257.1%-37.2%£69.17MN/A2,636.4390Gap DownORPHOpen OrphanN/AN/AN/AN/A£67.09M£34.71M-25.30179 Related Companies and Tools Related Companies Silence Therapeutics Competitors Amryt Pharma Competitors Origin Enterprises Competitors Bloomsbury Publishing Competitors Global Ports Competitors Aura Energy Competitors Alpha Real Trust Competitors Pharos Energy Competitors Kodal Minerals Competitors Open Orphan Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:IGC) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding India Capital Growth Please log in to your account or sign up in order to add this asset to your watchlist. Share India Capital Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access